MRI-defined sacroiliitis and spinal inflammation in chronic back pain: real-world patterns in axial spondyloarthritis and axial psoriatic arthritis
Clicks: 2
ID: 318944
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #44 of 46 articles by views in Rheumatology Advances in Practice
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Objectives To evaluate the diagnostic performance of MRI-defined sacroiliitis (SI) for axial spondyloarthritis (axSpA) in routine clinical practice, and to characterize inflammatory spinal lesions (ISL) and clinical factors associated with SI across non-psoriatic axSpA (nPsA-axSpA), axial psoriatic arthritis (axPsA), and non-inflammatory chronic back pain (NI-CBP). Methods We conducted a retrospective study of adults with chronic back pain who underwent sacroiliac joint and whole-spine MRI for suspected axSpA. Following longitudinal follow-up, patients were classified by expert rheumatologists as nPsA-axSpA, axPsA, or NI-CBP. Two blinded musculoskeletal radiologists independently assessed MRI scans for SI and ISL using ASAS/OMERACT definitions. Diagnostic accuracy metrics for MRI-defined SI were calculated using expert diagnosis as the reference standard, and multivariate logistic regression was used to identify predictors of SI. Results Ninety-five patients were included (29 nPsA-axSpA, 21 axPsA, 45 NI-CBP). MRI-defined SI showed high specificity (91%) and moderate sensitivity (77–83%) for axSpA diagnosis. Independent predictors of SI included age (OR 1.05 per year), regular physical activity (OR 3.50), expert-assessed inflammatory back pain (OR 35.11), and the number of spondyloarthritis features (OR 1.72). ISL were present in 40% of patients overall and were most prevalent in axPsA (76%). In axPsA, ISL frequently occurred in the absence of SI and displayed a broader and more heterogeneous distribution. Conclusion MRI-defined sacroiliitis is highly specific but insufficient as a standalone diagnostic tool for axSpA in real-world settings and should be interpreted in context.
| Reference Key |
openalex_W7166011219
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mauricio Parada, M. Molina, Daniel Ríos, Daniela Suárez, Mauricio Ochoa, Natalie Hitchin, Cristóbal Bravo, Nancy Guzmán, Pablo Barahona, Annelise Goecke Sariego |
| Journal | Rheumatology Advances in Practice |
| Year | 2026 |
| DOI |
10.1093/rap/rkag072
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.